Welcome to CDC stacks | VEB-1 in Achromobacter xylosoxidans from Cystic Fibrosis Patient, France - 16232 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
VEB-1 in Achromobacter xylosoxidans from Cystic Fibrosis Patient, France
  • Published Date:
    Nov 2006
  • Source:
    Emerg Infect Dis. 12(11):1737-1739.
Filetype[PDF-95.09 KB]


No Related Documents.
You May Also Like:
  1. Nosocomial Infections with IMP-19−Producing Pseudomonas aeruginosa Linked to Contaminated Sinks, France
    Personal Author:
    Amoureux, Lucie; Riedweg, Karena; Chapuis, Angélique; Bador, Julien; Siebor, Eliane; Péchinot, André; Chrétien, Marie-Lorraine; de Curraize, Claire; Neuwirth, Catherine;
    Published:
    Feb 2017
    Source:
    Emerg Infect Dis. 23(2):304-307.
    Description:
    We isolated IMP-19-producing Pseudomonas aeruginosa from 7 patients with nosocomial infections linked to contaminated sinks in France. We showed that blaIMP-19 was located on various class 1 integrons among 8 species of gram-negative bacilli detected...
    File Type:
    Filetype[PDF - 671.70 KB]
  2. Outbreak of Achromobacter xylosoxidans and Ochrobactrum anthropi Infections after Prostate Biopsies, France, 2014
    Personal Author:
    Haviari, Skerdi; Cassier, Pierre; Dananché, Cédric; Hulin, Monique; Dauwalder, Olivier; Rouvière, Olivier; Bertrand, Xavier; Perraud, Michel; Bénet, Thomas; Vanhems, Philippe;
    Published:
    Aug 2016
    Source:
    Emerg Infect Dis. 22(8):1412-1419.
    Description:
    We report an outbreak of healthcare-associated prostatitis involving rare environmental pathogens in immunocompetent patients undergoing transrectal prostate biopsies at Hôpital Édouard Herriot (Lyon, France) during August 13-October 10, 2014. Desp...
    File Type:
    Filetype[PDF - 900.02 KB]
  3. Infection by Ralstonia Species in Cystic Fibrosis Patients: Identification of R. pickettii and R. mannitolilytica by Polymerase Chain Reaction
    Personal Author:
    Coenye, Tom; Vandamme, Peter; LiPuma, John J.;
    Published:
    Jul 2002
    Source:
    Emerg Infect Dis. 8(7):692-696.
    Description:
    The frequency of respiratory tract infections caused by Ralstonia species in persons with cystic fibrosis (CF) and the role of these species in CF pulmonary disease are not well documented. In part, this lack of documentation may be attributed to the...
    File Type:
    Filetype[PDF - 367.46 KB]
  4. Inquilinus limosus and Cystic Fibrosis
    Personal Author:
    Bittar, Fadi; Leydier, Anne; Bosdure, Emmanuelle; Toro, Alexandre; Reynaud-Gaubert, Martine; Boniface, Stéphanie; Stremler, Nathalie; Dubus, Jean-Christophe; Sarles, Jacques; Raoult, Didier; Rolain, Jean-Marc;
    Published:
    Jun 2008
    Source:
    Emerg Infect Dis. 14(6):993-995.
    File Type:
    Filetype[PDF - 134.50 KB]
  5. Development of Levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis
    Personal Author:
    Stockmann, Chris; Sherwin, Catherine M.T.; Ampofo, Krow; Spigarelli, Michael G.;
    Published:
    Dec 10 2013
    Source:
    Ther Adv Respir Dis. 8(1):13-21.
    Description:
    Inhaled therapies allow for the targeted delivery of antimicrobials directly into the lungs and have been widely used in the treatment of cystic fibrosis (CF) acute pulmonary exacerbations. Nebulized levofloxacin solution (MP-376) is a novel therapy ...
    File Type:
    Filetype[PDF - 174.81 KB]